bpc 157 and 500 (10mg) + TB (10mg) Blend BPC-157 vs TB-500: Recovery Peptide

Consider using nurse case management

The gap between low frequency and high anxiety is real: even a small percentage feels large when it happens to you

FDA reviewers cited limited human clinical evidence and unresolved safety concerns, and the agency will make the final decision

Even safety data on TB-500 (synthetic TB4) is relatively scarce, with only a few studies reporting the potential side effects of its systemic application: In a 2010 study in 10 participants, TB4 caused occasional mild to moderate symptoms like headache and dizziness but no serious reactions or toxicities, even at doses up to 1260mg, administered daily for up to two weeks